While hypertension and dyslipidemia rates were comparable at 12 and 24 months, at 36 months, patients who had received preoperative GLP-1 RAs had higher rates of hypertension (50.0% vs. 24.0%) and dyslipidemia (35.3% vs. 21.2%). The gene discussed is GLP1R; the disease is hypertensive disorder.